Immunotherapy for pancreatic cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00432-016-2119-2.pdf
Reference74 articles.
1. Abate-Daga D, Rosenberg SA, Morgan RA (2014) Pancreatic cancer: hurdles in the engineering of CAR-based immunotherapies. Oncoimmunology 18:e291194
2. Abou-Alfa GK, Chapman PB, Feilchenfeldt J, Brennan MF, Capanu M, Gansukh B et al (2011) Targeting mutated K-ras in pancreatic adenocarcinoma using an adjuvant vaccine. Am J Clin Oncol 34:321–325
3. Amedei A, Niccolai E, Prisco D (2014) Pancreatic cancer: role of the immune system in cancer progression and vaccine based immunotherapy. Hum Vaccin Immunother 10:3354–3368
4. Anjali N, Sheetal M, Kircher M, Nimeiri HS, Benson AB, Rademaker A et al (2015) Results of the phase Ib study of ipilimumab and gemcitabine for advanced pancreas cancer. J Clin Oncol 33:(suppl; abstr e15281)
5. Asahara S, Takeda K, Yamao K, Maguchi H, Yamaue H (2013) Phase I/II clinical trial using HLA-A24-restricted peptide vaccine derived from KIF20A for patients with advanced pancreatic cancer. J Transl Med 11:291. doi: 10.1186/1479-5876-11-291
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems;Pharmaceutics;2023-09-21
2. An EGFR/HER2-targeted conjugate sensitizes gemcitabine-sensitive and resistant pancreatic cancer through different SMAD4-mediated mechanisms;Nature Communications;2022-09-20
3. An immune-related gene prognostic risk index for pancreatic adenocarcinoma;Frontiers in Immunology;2022-07-26
4. The Impact of a Centralised Pancreatic Cancer Service: a Case Study of Wales, UK;Journal of Gastrointestinal Surgery;2021-09-10
5. Analysis of T‐cell receptor repertoire in peripheral blood of patients with pancreatic cancer and other pancreatic diseases;Journal of Cellular and Molecular Medicine;2021-03-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3